{"count": 2, "results": [{"_id": "33447039", "pmid": 33447039, "pmcid": "PMC7802015", "title": "Clinical Characteristics, Treatment Outcomes, and its Predictors Among Hospitalized Stroke Patients in Ambo University Referral Hospital, West Ethiopia: A Retrospective Hospital-Based Study", "journal": "Vasc Health Risk Manag", "authors": ["Gadisa DA", "Busawa GB", "Gebremariam ET", "Tefera GM", "Belete KT", "Taye GM", "Meskele LB", "Gudeta BM", "Gelaw BK"], "date": "2021-01-05T00:00:00Z", "doi": "10.2147/VHRM.S287465", "meta_date_publication": "2020", "meta_volume": "16", "meta_issue": "", "meta_pages": "591-604", "score": 50244.65, "text_hl": "Likely, 48 (53.6%) @SPECIES_9606 @@@patients@@@ from @DISEASE_Cerebral_Infarction @DISEASE_MESH:D002544 @@@ischemic stroke@@@ and 10 (50.0%) @SPECIES_9606 @@@patients@@@ from @<m>DISEASE_Hemorrhagic_Stroke</m> @DISEASE_MESH:D000083302 @@@hemorrhagic stroke@@@ were frequently discharged with @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@+@CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Gadisa DA, Busawa GB, Gebremariam ET, Tefera GM, Belete KT, Taye GM, Meskele LB, Gudeta BM, Gelaw BK. Clinical Characteristics, Treatment Outcomes, and its Predictors Among Hospitalized Stroke Patients in Ambo University Referral Hospital, West Ethiopia: A Retrospective Hospital-Based Study Vasc Health Risk Manag. 2020;16():591-604. PMID: 33447039", "BibTeX": "@article{33447039, title={Clinical Characteristics, Treatment Outcomes, and its Predictors Among Hospitalized Stroke Patients in Ambo University Referral Hospital, West Ethiopia: A Retrospective Hospital-Based Study}, author={Gadisa DA and Busawa GB and Gebremariam ET and Tefera GM and Belete KT and Taye GM and Meskele LB and Gudeta BM and Gelaw BK}, journal={Vasc Health Risk Manag}, volume={16}, pages={591-604}}"}}, {"_id": "28972004", "pmid": 28972004, "title": "Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).", "journal": "Circulation", "authors": ["Bohula EA", "Wiviott SD", "Giugliano RP", "Blazing MA", "Park JG", "Murphy SA", "White JA", "Mach F", "Van de Werf F", "Dalby AJ", "White HD", "Tershakovec AM", "Cannon CP", "Braunwald E"], "date": "2017-12-19T00:00:00Z", "doi": "10.1161/CIRCULATIONAHA.117.029095", "meta_date_publication": "2017 Dec 19", "meta_volume": "136", "meta_issue": "25", "meta_pages": "2440-2450", "score": 50044.613, "text_hl": "There was a nonsignificant reduction in the first event of @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ of any etiology (4.2% versus 4.8%; hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.73-1.00; P=0.052) with @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ versus placebo/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, driven by a significant 21% reduction in @DISEASE_Cerebral_Infarction @DISEASE_MESH:D002544 @@@ischemic stroke@@@ (3.4% versus 4.1%; HR, 0.79; 95% CI, 0.67-0.94; P=0.008) and a nonsignificant increase in @<m>DISEASE_Hemorrhagic_Stroke</m> @DISEASE_MESH:D000083302 @@@hemorrhagic stroke@@@ (0.8% versus 0.6%; HR, 1.38; 95% CI, 0.93-2.04; P=0.11). ", "citations": {"NLM": "Bohula EA, Wiviott SD, Giugliano RP, Blazing MA, Park JG, Murphy SA, White JA, Mach F, Van de Werf F, Dalby AJ, White HD, Tershakovec AM, Cannon CP, Braunwald E. Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation. 2017 Dec 19;136(25):2440-2450. PMID: 28972004", "BibTeX": "@article{28972004, title={Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).}, author={Bohula EA and Wiviott SD and Giugliano RP and Blazing MA and Park JG and Murphy SA and White JA and Mach F and Van de Werf F and Dalby AJ and White HD and Tershakovec AM and Cannon CP and Braunwald E}, journal={Circulation}, volume={136}, number={25}, pages={2440-2450}}"}}]}